Myocardial InfarctionDisease Models, AnimalMesenchymal Stem Cell TransplantationInjectionsMyocardiumVentricular RemodelingMyocytes, CardiacNeovascularization, PhysiologicStem Cell TransplantationEchocardiographyMesenchymal Stromal CellsRats, Sprague-DawleyInfarctionElectrocardiographyCerebral InfarctionAngioplasty, Balloon, CoronaryThrombolytic TherapyCoronary AngiographyTime FactorsAnterior Wall Myocardial InfarctionMyocardial ReperfusionRisk FactorsTreatment OutcomeProspective StudiesStreptokinaseCreatine KinaseDogsCoronary Care UnitsSwineVentricular Function, LeftFibrinolytic AgentsGenetic TherapyCoronary DiseasePrognosisAngina PectorisPlatelet Aggregation InhibitorsFollow-Up StudiesAngina, UnstablePredictive Value of TestsStentsPercutaneous Coronary InterventionMyocardial RevascularizationCoronary ThrombosisRecurrenceMyocardial IschemiaCoronary VesselsShock, CardiogenicCoronary Artery DiseaseInferior Wall Myocardial InfarctionRisk AssessmentVentricular Dysfunction, LeftHospital MortalityCoronary CirculationStroke VolumeAcute DiseaseRetrospective StudiesChest PainBiological MarkersHeart FailureHeartCoronary Artery BypassProportional Hazards ModelsRegistriesIncidenceStrokeAspirinHeart VentriclesAcute Coronary SyndromeCohort StudiesTissue Plasminogen ActivatorSurvival AnalysisArrhythmias, CardiacHeart Rupture, Post-InfarctionMultivariate AnalysisHospitalizationClinical Enzyme TestsCase-Control StudiesDrug-Eluting StentsCardiac CatheterizationHemorrhageTroponin TRiskDeath, Sudden, CardiacTroponin ICardiovascular AgentsAdrenergic beta-AntagonistsMyocardial Reperfusion InjuryHemodynamicsLogistic ModelsSurvival RateTiclopidineThrombosisCardiovascular DiseasesAge FactorsCardiotonic AgentsKaplan-Meier EstimateRandomized Controlled Trials as TopicChi-Square DistributionCoronary OcclusionCoronary Stenosis